Oxygen robot from Danish company reduces risk and supports nurses to handle more COVID-19 patients

The Danish company, O2matic, has in collaboration with Hvidovre Hospital developed an oxygen robot that can improve the supply of oxygen to patients infected with COVID-19 and simultaneously reduce the contamination risk for healthcare professionals by limiting the physical contact with infected patients. The robot is already in use at many hospitals in Denmark and 10 other countries including Italy, and will be further implemented in more than 10 new countries in the coming months.

Many of the patients currently admitted to hospitals with the coronavirus suffer from serious respiratory infections that can lead to breathing problems and require oxygen treatment.

O2matic is an innovative oxygen robot that can deliver the correct amount of oxygen to patients.

In the beginning of March, the first corona patients were treated by O2matic’s oxygen robot with good results. The oxygen for the patients has so far been dosed manually by nurses up to 50 times per day, taking up much of the staff’s limited time, especially considering the safety measures taken by the staff when attending the patients. The oxygen robot measures the oxygen level in the patient’s blood every second and accordingly adjusts the dose of oxygen - ensuring that the patient receives the right amount of oxygen. Based on this, The Capital Region of Denmark has ordered 40 oxygen robots for use at hospitals in the entire region.

"With the COVID-19 crisis, we both need more equipment and more staff, and time is essential. It is, therefore, a big advantage that robot technology, in this case, oxygen robots, can help us reduce manual tasks and release the pressure on our staff”, says Sophie Hæstorp Andersen, who chairs the Region Council at the Capital Region, according to a press release.

O2matic is already preparing the production of the next 500 oxygen robots, which are all produced by the high-tech company, Alpha Electronics in Denmark.

The solution of the oxygen robot is funded by multiple investors and funds, including Innovation Fund Denmark. Furthermore, O2matic recently won the Innovation Fund Denmark’s main research prize, The Grand Solutions Prize, at the annual prize ceremony.

Read more about the solution here.